CUNIPRAVAC-RHD ΕΝΕΣΙΜΟ ΓΑΛΑΚΤΩΜΑ
CUNIPRAVAC-RHD ΕΝΕΣΙΜΟ ΓΑΛΑΚΤΩΜΑ
Not authorised
- Rabbit haemorrhagic disease virus, type 1, strain 3116-AP, Inactivated
Product identification
Medicine name:
CUNIPRAVAC-RHD ΕΝΕΣΙΜΟ ΓΑΛΑΚΤΩΜΑ
Active substance:
- Rabbit haemorrhagic disease virus, type 1, strain 3116-AP, Inactivated
Target species:
-
Rabbit
Route of administration:
-
Subcutaneous use
Product details
Active substance and strength:
-
Rabbit haemorrhagic disease virus, type 1, strain 3116-AP, Inactivated0.05/gram(s)0.50millilitre(s)
Pharmaceutical form:
-
Emulsion for injection
Withdrawal period by route of administration:
-
Subcutaneous use
-
Rabbit
-
Meat and offal21day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI08AA01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Surrendered
Authorised in:
-
Greece
Package description:
- Available only in Greek
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Complete application (stand-alone)
Marketing authorisation holder:
- Laboratorios Hipra S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
- Laboratorios Hipra S.A.
Responsible authority:
- National Organization For Medicines
Authorisation number:
- 34643/93/Κ-2629/12-04-1994/K-0083401
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
